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ABSTRACT
Objective To estimate the cost effectiveness of four
different lifestyle interventions for knee pain.
DesignCostutilityanalysisofrandomisedcontrolledtrial.
Setting Five general practices in the United Kingdom.
Participants 389 adults aged ≥45 with self reported knee
pain and body mass index (BMI) ≥28.
Interventions Dietary intervention plus quadriceps
strengthening exercises, dietary intervention, quadriceps
strengthening exercises, and leaflet provision.
Participants received home visits over a two year period.
Main outcome measure Incremental cost per quality
adjusted life year (QALY) gained over two years from a
health service perspective.
ResultsAdviceleafletwasassociatedwithameanchange
in cost of −£31, and a mean QALY gain of 0.085. Both
strengthening exercises and dietary intervention were
more effective (0.090 and 0.133 mean QALY gain,
respectively) but were not cost effective. Dietary
intervention plus strengthening exercises had a mean
cost of £647 and a mean QALY gain of 0.147 and was
estimated to have an incremental cost of £10469 per
QALY gain (relative to leaflet provision), and a 23.1%
probability of being cost effective at a £20000/QALY
threshold.
Conclusion Dietary intervention plus strengthening
exercises was estimated to be cost effective for
individuals with knee pain, but with a large level of
uncertainty.
Trial registration ISRCTN93206785.
INTRODUCTION
Nearly half of people aged >50 report having knee
pain at some point in the past year, and, of these, a
third report consulting their general practitioner with
regard to their knee pain.
1 Previous economic evalua-
tionsforpeoplewithkneepainhaveestimatedonlythe
cost effectiveness of different exercise programmes
and have not focused on those who are overweight.
23
The importance of such an evaluation was highlighted
by a recent study that found that there was an early
relianceonpharmacologicaltreatmentsattheexpense
ofnon-pharmacologicaltreatmentssuchasweightloss,
exercise, and the provision of written advice.
4 This
occurred despite the fact that these three treatments
have been recommended as first line treatments for
people with knee pain.
5
A previous study evaluated a weight reduction
programme
6 as weight loss has been shown to be asso-
ciated with an improvement in the symptoms of knee
osteoarthritis,
7 of which pain is the principal feature.
8
Indeed, it has been estimated that between a quarter
and a half ofall knee osteoarthritis mightbe prevented
by eliminating obesity.
9 The value of a quadriceps
strengthening exercise programme has also been esti-
mated as there is evidence that quadriceps weakness is
associatedwithdisabilityandpaininpatientswithknee
osteoarthritis
1011 and that a home based exercise pro-
gramme can help improve self reported knee pain and
function.
1213
We investigated the cost effectiveness of four inter-
ventions designed to alleviate knee pain in overweight
and obese adults.
METHODS
Participants
The lifestyle interventions for knee pain study com-
pared the effectiveness
14 and cost effectiveness of four
differentinterventiongroups:dietaryinterventionplus
quadriceps strengthening exercises, dietary inter-
vention, quadriceps strengthening exercises, and leaf-
let provision. We sent an ascertainment questionnaire
to all registered patients aged ≥45 in five Nottingham
general practices. We did not contact terminally ill
patients and those with psychiatric illness, dementia,
or any other incapacitating disease that their general
practitioner thought made them unsuitable for partici-
pation. A local media campaign was also conducted to
improve recruitment. Recruitment started in May
2003 and ended in March 2005. Responding indivi-
duals were recruited into the study if they reported
that they had had knee pain on most days of the past
month, had a body mass index (BMI) >28.0, and gave
consent to be randomised to one of the four
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mised to dietary intervention because we anticipated a
higher rate of attrition in this group).
Interventions
The interventions are described more fully in the
accompanying clinical paper.
14 Participants in both
the dietary intervention groups were visited by a dieti-
tian and received a personalised dietary plan that
would create a deficit of 2.5 MJ (600 kcal) a day.
They were scheduled to receive visits every month in
the first six months and every other month for the
remainder of the 24 month intervention period. Parti-
cipants in the exercise groups were taught exercises
designed to strengthen the quadriceps (thigh) muscles
and included resistance exercises, some of which were
taught with rubber exercise (dyno) bands of varying
strength. They were asked to repeat these exercises at
home on a daily basis and were scheduled to receive
visits every four months throughout the 24 month
intervention period. The final intervention was the
provision of a leaflet based on the Arthritis Research
Campaign(ARC)OsteoarthritisoftheKneeleaflet(www.
arc.org.uk) but leaflets had all exercise and dietary
advice removed (this was considered equivalent to
standard care).
Measuring costs
Foreachparticipantweestimatedtheoverallchangein
cost to the health service over the two year trial period
by summing the costs associated with visits by health-
care professionals and the change in the costs asso-
ciated with analgesic use. All costs were estimated in
UKsterling(£)at2006-7financialyearcosts.Coststhat
occurred in the second year were discounted at the
current recommended rate of 3.5%.
15
Visit costs—Throughout the study each healthcare
professionalrecordedthe number ofvisits toeach par-
ticipant. All visits were made to provide advice, with
the exception of visits to the leaflet group, where visits
were undertaken to record trial outcome information
such as weight and the percentage of body fat. As such
visits would not be made if the intervention was routi-
nely provided in the NHS, we assumed that the visit
cost for all participants who received the leaflet was
equivalent to zero. The unit cost of all other visits was
estimated from a previously published source
16 and
includedtheadditionaltimeandtravelcostsassociated
with home visits. The cost of providing dyno bands to
participants who were allocated to either of the
strengthening exercise groups was also estimated
(www.physioroom.com).
Analgesic costs—At baseline, participants were asked
to report whether they currently used analgesics
(obtained by prescription or over the counter) and, if
so, which type. The same question was also asked of
participants at 12 and 24 months after randomisation.
Thesedata were combined with unit cost data
17 to esti-
mate the four weekly cost of analgesics. When data
were missing, we used multiple imputation
18 to gener-
ate replacement cost values for participants who did
notprovideinformationonanalgesicuseataparticular
follow-uppoint.Subsequently,foreachparticipant,we
used the area under the curve method,
19 with baseline
adjustment, to estimate the change in analgesic costs,
over the 24 month trial period. The mean change in
analgesic costs could thereby be calculated for each
intervention group, and this was added to the mean
visit cost to estimate the mean overall change in cost
to the health service for each of the four intervention
groups.
Use of other resources—Additionally, to provide an
indication of whether participants who received a par-
ticularinterventionhadarelativelyhighorlowlevelof
useofotherhealthserviceresources,weaskedasubset
of participants (at one year after randomisation) how
many visits related to knee pain (in the preceding four
weeks) they had made to the general practitioner,
nurse, and other healthcare professionals or hospital
(outpatient visits and inpatient admissions were
recorded). For practical reasons, the subsample con-
sistedof229consecutiveparticipantswhohadreached
the one year follow-up between June 2004 and August
2005. We used one way analysis of variance to assess
whether there were significant differences in the mean
number of visits across the four intervention groups.
Measuring outcomes
The accompanying clinical paper
14 details the results
according to the trial primary outcome measure of
pain, as assessed by the Western Ontario and McMas-
ter Universities osteoarthritis index (WOMAC).
20 To
estimate the impact that each intervention had on
health related quality of life we asked participants to
complete the EQ-5D
21 at baseline and at six, 12, and
24 months after randomisation. This enabled us to
carryoutacostutilityanalysis,
22inwhichwecompared
the benefits of different healthcare interventions on a
commonscale(utilityismeasuredonascalewhere0is
equivalenttodeathand1isequivalenttofullhealth).A
utility score was assigned to each of the health state
descriptions elicited by the EQ-5D with the York A1
tariff,
23 on which scores range between −0.594 and
1.00.Afterusingmultipleimputation
18topredictmiss-
ing EQ-5D scores, we used the area under the curve
method (with adjustment for baseline differences)
19 to
estimate, for each participant, the quality adjusted life
year (QALY) gain/loss that accrued over the trial per-
iod. QALY gains that accrued in the second year were
discountedat3.5%,andthemeanQALYgainwasesti-
mated for each of the four intervention groups.
Cost effectiveness
The level of cost effectiveness was estimated from the
viewpoint of the NHS. We excluded dominated inter-
ventions (which had a higher mean overall change in
cost to the health service and lower mean QALY gain
than anotherintervention) and interventions that were
subject to extended dominance (as combinations of
other interventions could provide a greater benefit at
equivalentcost).
24Subsequently,wecalculatedthecost
effectiveness of non-excluded interventions by
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mental cost effectiveness ratio) associated with each
interventiongroup,relativetothenextbestalternative.
Confidenceintervalsfortheincrementalcosteffective-
ness ratio were also computed by using the bootstrap
technique.
25 In line with guidance provided by the
National Institute of Health and Clinical Excellence
(NICE)
26 we sought to identify the most cost effective
intervention by comparing the incremental cost effec-
tiveness ratio with a cost effectiveness threshold (λ)o f
£20000-£30000 per QALY.
Decision uncertainty
Toestimatethelevelofuncertaintyassociatedwiththe
decision as to which intervention was most cost effec-
tive we used probabilistic methods to estimate the cost
effectiveness acceptability curve for each intervention
group, where the curve depicts the probability that an
intervention is cost effective at different levels of the
cost effectiveness threshold.
2728
Sensitivity analysis
Oneofourmainassumptionswasthatallvisitstothose
receiving the leaflet were undertaken solely to record
trial outcome information and that these visits would
notbemadeiftheinterventionwasroutinelyprovided
in the NHS. Rather than assigning a zero cost to the
visits received by those in the leaflet arm, in the sensi-
tivityanalysisweassumedthattheyshouldbeassigned
the same unit cost as those who received quadriceps
strengthening exercises.
RESULTS
Participants
Questionnaires were returned by 8004 of the 12408
individuals (65%) who were sent an ascertainment
questionnaire. Of these, 320 were eligible to take part
and consented to be randomised to one of the four
interventions. An additional 69 participants were
recruitedvia the media campaign.In total,109 partici-
pants were randomised to receive dietary intervention
plusquadricepsstrengtheningexercises,122todietary
intervention,82toquadricepsstrengtheningexercises,
and 76 to leaflet provision. The mean age of the 389
participants was 61.3 and 257 (66%) were women.
According to BMI, 90 (23%) were classified as over-
weight (BMI 25-<30), 196 (50%) as class I obese (30-
<35),65(17%)asclassIIobese(35-<40),and38(10%)
as class III obese (≥40).
Costs
The mean number of visits received by participants
randomised to dietary intervention plus quadriceps
strengthening exercises was 11.19 (range 0-16), com-
pared with 13.46 for dietary intervention alone (range
0-17), 4.95 for quadriceps strengthening exercises
(range0-7),and6.05(range0-7)forthosewhoreceived
the leaflet (more participants withdrew from the exer-
cise groups, which might explain why, on average,
they received fewer visits than those who received a
leaflet, see accompanying clinical paper for further
information
14). The estimated unit cost per home visit
was £54.60 for both the dietary intervention groups,
and £44.60 for those who received the quadriceps
strengthening exercises; the dyno bands cost £5.50.
Over the two year trial period the estimated mean
visit cost for those who received dietary intervention
plus quadriceps strengthening exercises was £615.64
compared with £735.57 for the dietary intervention,
£214.66 for the quadriceps strengthening exercises,
and £0.00 for the leaflet (table 1).
At baseline, 12 months, and 24 months the associated
questiononanalgesiccostswascompletedbyanaverage
of 287 participants (74%). After imputation, for each of
Table 1 |Estimates of mean change in cost (£) and mean (SD) QALY gain associated with each intervention and their
component parts
Dietary intervention plus
strengthening exercises Dietary intervention Strengthening exercises Leaflet provision
Analgesic costs:
Baseline 6.23 (6.19) 6.59 (5.72) 6.60 (6.22) 7.86 (7.12)
12 month 5.14 (5.53) 5.62 (5.79) 5.80 (6.60) 6.26 (6.58)
24 month 5.88 (6.05) 5.75 (5.05) 6.76 (6.45) 6.15 (5.09)
Change in cost (over two
years)
−16.22 (118.00) −17.62 (102.74) −9.17 (94.37) −31.07 (136.17)
Visit costs (over two years) 631.86 (324.41) 753.19 (246.01) 223.83 (115.10) 0.00 (0.00)
Overall change in cost 615.64 (323.20) 735.57 (260.13) 214.66 (128.02) −31.07 (129.78)
EQ-5D score:
Baseline 0.542 (0.274) 0.531 (0.305) 0.587 (0.245) 0.555 (0.281)
6 month 0.643 (0.211) 0.603 (0.275) 0.649 (0.254) 0.591 (0.251)
12 month 0.608 (0.255) 0.612 (0.267) 0.626 (0.250) 0.617 (0.260)
24 month 0.642 (0.245) 0.609 (0.279) 0.649 (0.260) 0.601 (0.266)
QALY gain 0.147 (0.340) 0.133 (0.415) 0.090 (0.388) 0.085 (0.349)
Incremental cost (v leaflet) 646.71 766.64 245.73 —
Incremental effect (v leaflet) 0.062 0.048 0.005 —
ICER 10 649 Dominated ED —
ICER=incremental cost effectiveness ratio; ED=extended dominance.
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were lower at follow-up than at baseline (table 1). We
combined the estimates of costs for visits and analgesics
to estimate the overall change in cost to the health ser-
vice: this ranged between an increase in mean cost of
£735.57 (for the dietary intervention) and a decrease in
mean cost of £31.07 (for the leaflet) (table 1).
To determine use of other health services, one year
after randomisation we contacted 188 (82%) of the pro-
posed subsample of 229 participants. There was no sig-
nificant difference across each of the four intervention
groups in the number of knee pain related visits to the
general practitioner, nurse, other healthcare profes-
sionals, or hospital in the preceding four weeks (table 2).
Outcomes
At baseline, six, 12, and 24 months an average of 336
participants (86%) completed the EQ-5D. Table 1
shows the mean scores at each of these time points
(after imputation) for the four interventions groups,
along with the mean QALY gain (over the two year
trial period). Leaflet provision was associated with the
lowest gain (0.085 QALYs), and dietary intervention
plusquadricepsstrengtheningexerciseswasassociated
with the largest gain (0.147 QALYs).
Cost effectiveness
Comparison of the mean change in cost and mean
QALY gain (table 1) across the four intervention
groups showed that dietary intervention alone was
dominated by dietary intervention plus quadriceps
strengthening exercises. Similarly, quadriceps
strengthening exercises was not cost effective as it was
subject to extended dominance (combinations of leaf-
let provision and dietary intervention plus quadriceps
strengthening exercises could provide a higher benefit
at equivalent cost). Compared with leaflet provision,
dietary intervention plus quadriceps strengthening
exercises was both more costly (mean incremental
cost £646.71, 95% confidence interval £578.15 to
£709.62) and more effective (mean incremental effect
0.062, −0.035 to 0.167), with an estimated incremental
cost per QALY gain (incremental cost effectiveness
ratio) of £10469.44 (£3738.28 to dominated) (table 1).
Thus,dietaryinterventionplusquadricepsstrengthen-
ing exercises is likely to be deemed cost effective as it
has an incremental cost effectiveness ratio that is more
favourable than a threshold of £20000-£30000 per
QALY.
Decision uncertainty
Thecosteffectivenessacceptabilitycurvesindicatethat
forthresholdvalues≥£5000perQALYtheprobability
of cost effectiveness was <30% for all four inter-
ventions, showing that there is a large level of uncer-
tainty associated with the decision as to which
intervention is the most cost effective (figure). The
probability that dietary intervention plus quadriceps
strengthening exercises was the most cost effective
intervention was 23.1% at λ=£20000 per QALY.
Sensitivity analysis
When we assumed that the unit cost of a visit for those
in the leaflet arm of the trial was equivalent to that in
the quadriceps strengthening exercises arm (£44.60),
the estimated mean cost per participant in the leaflet
arm was £235.83. In this situation leaflet provision
wouldhavebeendominatedbyquadricepsstrengthen-
ing exercises. The incremental cost effectiveness ratio
for dietary intervention plus quadriceps strengthening
exercises would thereby have been estimated to be
more favourable at £6148.59 compared with quadri-
ceps strengthening exercises.
DISCUSSION
In this randomised controlled trial of four inter-
ventions forknee painin overweightand obese adults,
dietary intervention plus quadriceps strengthening
exercises was associated with the highest mean gain
Table 2 |Mean number of reported visits related to knee pain in preceding four weeks at one year after randomisation within
each of intervention group
Dietary intervention plus
strengthening exercises
Dietary
intervention
Strengthening
exercises Leaflet provision F statistic
General practitioner 0.14 0.18 0.19 0.15 0.104
Nurse 0.39 0.47 0.47 0.41 0.105
Other healthcare professionals 0.23 0.30 0.09 0.20 0.931
Outpatient visits 0.36 0.28 0.50 0.28 0.606
Inpatient admissions 0.02 0.00 0.00 0.02 0.660
Cost effectiveness threshold (£/QALY)
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estimated incremental cost effectiveness ratio of
£10469. As this value falls below a threshold value of
£20000-£30000 per QALY, the provision of dietary
intervention plus quadriceps strengthening exercises
represents a cost effective use of scarce healthcare
resources. The probability that this was the most cost
effective intervention, however, was only 23.1% when
λ=£20000/QALY.
Strengths and weaknesses
Thoughourtwoyearfollow-upperiodwaslongerthan
in many other clinical trials, we did not estimate the
long term costs and benefits of these interventions.
Furthermore, as we did not systematically monitor
compliance with either the dietary plan or exercise
advice, our ability to predict the long term effects of
these interventions is diminished. That said, were the
benefits of providing dietary intervention plus quadri-
ceps strengthening exercises to be sustained beyond
the two year follow-up period then it is likely that,
had the analysis taken a lifetime perspective, the esti-
mates as to the cost effectiveness of this intervention
would have been more favourable. Similarly, within
this study we did not evaluate the provision of group
exercise programmes, which others have shown to be
effective,
3anditmightbethat,becauseofeconomiesof
scale, it is more cost effective to use group based exer-
ciseclassesratherthanundertakeonetoonehealthcare
professional visits.
Comparison to other studies
We are aware of two studies that have estimated the
cost effectiveness of different interventions for people
with knee pain (in non-overweight populations),
23
though only one of these studies measured effective-
ness in terms of utility.
3 Our results are in contrast
withthoseofHurleyetal,whofoundthattheprovision
of a rehabilitation programme by a physiotherapist (in
addition to usual care) was less effective, in terms of
QALYs gained, than usual primary care.
3 Our results
are more in line with those studies that have used
WOMAC to measure effectiveness. Thomas et al
found that, compared with either telephone contact
or no intervention, an exercise programme was esti-
mated to be more effective according to WOMAC
but also more costly and was not associated with a
reduction in other health costs.
2 Hurley et al found
that, compared with usual care, a greater proportion
of those who received rehabilitation by a physio-
therapist had a clinically meaningful improvement
according to WOMAC but that this was also more
costly.
3
Explanations
The finding that dietary intervention plus quadriceps
strengthening exercises was estimated to be cost effec-
tive aligns with the findings of the accompanying clin-
ical paper,
14 in which strengthening exercises were
associated with a reduction in pain according to
WOMAC and that both dietary intervention and
strengthening exercises improved functioning accord-
ingtoWOMAC.Additionally,thehighlevelofuncer-
taintyassociatedwiththeestimatesofcosteffectiveness
can bepartiallyexplainedby the factthat lessthantwo
thirds of those in the dietary intervention plus quadri-
ceps strengthening exercises group actually received a
net QALY gain over the two year period.
Implications and future research
The provision of dietary intervention plus quadriceps
strengthening exercises to individuals aged ≥45 with a
BMI ≥28 is likely to represent a cost effective use of
scarce NHS resources. There was, however, a large
level of uncertainty associated with this decision,
which was partially accounted for by the fact that
there was a high level of variation in the benefits that
different individuals received. Further research might
therefore focus on the value of personalised knee pain
interventions;someparticipantsmightfeeltheyneeda
high level of support, whereas others, after initial
instruction, might be quite able to adhere to the inter-
vention without further support. Here, one might also
consider a more thorough investigation of the impact
thattheseinterventionshaveonthenumberofvisitsto
other healthcare professionals related to knee pain.
Though we found no significant difference in this vari-
able in a subsample of patients at a single time point
(see table 2), it is conceivable that such services might
be affected as it has previously been shown that
patients with knee pain who received an exercise pro-
gramme had both significantly fewer general practice
consultations and used less pain relief than those who
received only an advice leaflet.
13
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WHAT IS ALREADY KNOWN ON THIS TOPIC
The prevalence of knee pain increases with age and for
those who are overweight
No assessment as to the cost effectiveness of dietary
interventionorquadricepsstrengtheningexercises,orboth,
has been made for overweight individuals
WHAT THIS STUDY ADDS
Provision of dietary intervention plus quadriceps
strengthening exercises was estimated to be cost effective
atathresholdof£20000perQALY,thoughtherewasalarge
level of associated uncertainty
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